Plasma ceramides relate to mild cognitive impairment in middle-aged men: The Maastricht Study.

Daan van Kruining,Mario Losen,Simone M Crivelli,Joost J A de Jong,Jacobus F A Jansen,Walter H Backes,Jennifer Monereo-Sánchez,Martin P J van Boxtel,Sebastian Köhler,David E J Linden,Miranda T Schram,Michelle M Mielke,Pilar Martinez-Martinez

Alzheimer's & dementia (Amsterdam, Netherlands)（2023）

引用 0|浏览16

暂无评分

摘要

Our results warrant further analysis of plasma ceramides as potential markers for MCI in middle-aged men. In contrast to previous studies, no associations of plasma sphingolipids with MCI or brain volumes were found in women, independent of age. These results highlight the importance of accounting for sex- and age-related factors when examining sphingolipid and CERT metabolism related to cognitive function.

查看译文

关键词

mild cognitive impairment,cognitive impairment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要